Skip to content

Clinical trials

Phase 1/2 Adenocarcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Phase: Phase 1/2 Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20052
20061
20081
20092
20104
20111
20121
20132
20141
20151
20161
20174
20183
20194
20204
20213
20224
20233
20243
20253
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Recruiting11
Unknown status6
Terminated5
Active, not recruiting5
Withdrawn3
Suspended2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center3
Abramson Cancer Center at Penn Medicine2
H. Lee Moffitt Cancer Center and Research Institute2
Immuneering Corporation2
Ohio State University Comprehensive Cancer Center2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2
AIO-Studien-gGmbH1
ARCA Biopharma, Inc.1
Acrotech Biopharma Inc.1
Alan Katz1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma56
Carcinoma, Non-Small-Cell Lung13
Neoplasms12
Pancreatic Neoplasms12
Neoplasm Metastasis10
Lung Neoplasms8
Colonic Neoplasms6
Ovarian Neoplasms5
Prostatic Neoplasms5
Stomach Neoplasms5

Trials

Showing 51 to 56 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.